Searching Content indexed under Consumer Protection by Ropes & Gray LLP ordered by Published Date Descending.
Links to Result pages
CCPA Amendments Pass As The California Legislative Session Draws To A Close
As the clock ticked to the close of California's 2019 legislative session on Friday the 13th, the California legislature
23 Sep 2019
New Banking Law Takes First Step In Rolling Back Dodd-Frank Reforms
On May 24, 2018, President Trump signed into law the Economic Growth, Regulatory Relief, and Consumer Protection Act (the "Act") ...
United States
29 May 2018
Ropes & Grayís Hedge Fund Update: June 2011
Effective July 16, 2011, certain derivatives provisions of the Dodd-Frank Act will become law, including provisions which expand the definition of a "commodity pool" to include a pooled investment vehicle that trades, or may trade, swaps (other than security-based swaps).
United States
17 Jun 2011
The SECís New Whistleblower Compensation Rules
On May 25, 2011, by a vote of 3 to 2, the SEC approved its whistleblower compensation rules substantially as proposed.
United States
6 Jun 2011
Potential Extension Of Compliance Date For Private Fund Investment Adviser Registration
The Securities and Exchange Commission (the "SEC") staff indicated today that the SEC is considering extending the compliance date for investment adviser registration for currently unregistered private fund advisers from July 21, 2011 until the first quarter of 2012.
United States
17 May 2011
SEC Proposes New Rules On Compensation Committee Independence And Adviser Conflicts
On March 30, 2011, the Securities and Exchange Commission proposed rules to implement provisions of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 relating to compensation committee membership and adviser conflicts.
United States
13 May 2011
FDA Chemist Charged With Trading On Confidential Information Related To Drug Approvals
The Securities and Exchange Commission ("SEC") and the Department of Justice ("DOJ") announced on March 29, 2011, that civil and criminal proceedings are being brought against Cheng Yi Liang, a chemist employed by the Food and Drug Administration ("FDA"), for alleged insider trading.
United States
13 May 2011
Links to Result pages